Misconceptions about the use of genetic tests in populations

Lancet

Volumn 357, Issue 9257, 2001, Pages 709-712

  Vineis, Paolo ^a   Schulte, Paul ^b   McMichael, Anthony J ^c  

^a Cancer Epidemiology Unit   (Italy)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

BREAST CANCER; COST BENEFIT ANALYSIS; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; HUNTINGTON CHOREA; ICELAND; LUNG CANCER; ONCOGENE; PENETRANCE; PHENYLKETONURIA; PRIORITY JOURNAL; REVIEW; SMOKING; XERODERMA PIGMENTOSUM;

EID: 0035799103     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04136-2     Document Type: Note

References (24)

1. The performance of a lifetime: A metaphor for the phenotype
2. Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review
3. Polymorphisms in the DNA repair gene XPD: Correlations with risk and age at onset of basal-cell carcinoma
4. Variable penetrance of breast cancer susceptibility genes
5. Gene-environment interaction and public health
6. The new genetics in clinical practice
7. Will genetics revolutionize medicine?
8. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
9. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trials - Multiple Outcomes of Raloxifene Evaluation
10. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women
11. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
12. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2
13. BRCA1 and BRCA2 gene mutations and risk of breast cancer: Public health perspectives
14. A cost-benefit analysis of genetic screening for susceptibility to occupational toxicants
15. Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention
16. Tobacco smoking
17. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer
18. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53
19. Editorial. This week in Science: p53 - The smoking gun?
20. Analysis of radon-associated squamous cell carcinoma of the lung for a p53 gene hotspot mutation
21. 2-adrenoceptor gene polymorphism, body weight, and physical activity
22. Population screening in haemochromatosis